Mutation in BRAF and SMAD4 associated with resistance to neoadjuvant chemoradiation therapy in locally advanced rectal cancer

Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer

Rolf Sauer, Heinz Becker, Werner Hohenberger et al. · New England Journal of Medicine · 2004 · 6.1K citations

Medicine, Oncology, Surgery +10

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

Eric Van Cutsem, Andrés Cervantes, René Adam et al. · Annals of Oncology · 2016 · 3.4K citations · Full text

Medicine, Oncology, Surgery +13

Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study

Michelle Landon, Jennifer Saam, Krystal Brown et al. · Oncology · 2015 · 1.9K citations · Full text

Life Sciences, Genetics, Oncology +17

Wild-Type <i>BRAF</i> Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer

Federica Di Nicolantonio, Miriam Martini, Francesca Molinari et al. · Journal of Clinical Oncology · 2008 · 1.6K citations · Full text

Medicine, Oncology, Pharmacology +17

Swedish Rectal Cancer Trial: Long Lasting Benefits From Radiotherapy on Survival and Local Recurrence Rate

Joakim Folkesson, Helgi Birgisson, Lars Påhlman et al. · Journal of Clinical Oncology · 2005 · 863 citations · Full text

Medicine, Oncology, Surgery +14